查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球血管造影套件市场 - 2022-2029
市场调查报告书
商品编码
1129252

全球血管造影套件市场 - 2022-2029

Global Angio Suites Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

介入肿瘤学中精密 CT 系统的技术进步预计将推动市场增长。

结合标准血管造影和横截面图像的组合血管造影 CT (AngioCT) 系统极大地受益于介入放射学。平板血管造影系统中的锥形束 CT (CBCT) 技术长期以来一直被用作介入手术期间的辅助横断面成像工具，但血管 CT 系统在卓越的软组织成像方面的独特优势和由于其对比分辨率和易于操作，人们对其在介入肿瘤学中的应用重新产生了兴趣。由于工作流程的改进提高了价格和易用性，Angio-CT 系统已成为独立配备 CBCT 的平板血管造影系统的竞争替代品。此外，通过将 CT 扫描仪的横截面图像与血管造影的透视图像相结合，我们可以更准确地规划肿瘤干预措施，将多种治疗结合在一个地方，跟踪术中治疗反应，减少并发症，改善治疗效果。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

限制

在预测期内，与安装血管造影套件相关的高成本、熟练使用血管造影套件的人员短缺、重建成像诊断设备的使用增加以及辐射暴露的高风险预计将增加。这是阻碍市场的因素之一。

行业分析

血管造影套件市场根据波特五力、供应链分析、报销方案、产品创新和定价分析等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

COVID-19 大流行对医疗保健系统和市场产生了适度影响。在冠状病毒活跃的大流行期间，心脏病和其他慢性病的病例有所增加。对血管造影套件的需求猛增，因为它是一种最先进的设备，用于可视化人体血管，尤其是动脉的内部，以进行准确和有效的诊断。随着 COVID-19 的激增，心脏病患者的激增增加了对现代血管造影套件的需求。美国疾病控制和预防中心正在推迟选择性心臟手术，例如冠状动脉造影和经皮冠状动脉介入治疗以治疗稳定的冠状动脉疾病，节省个人防护设备和病床等资源，以确保 COVID-19 患者的安全。我建议您服用照顾它。在 COVID 流行的早期阶段，预计美国心导管实验室的 STEMI 激活减少 38%，与西班牙 40% 的减少相当。

此外，大流行还将扰乱供应炼和流程。许多公司转移到其他地区以确保产品可用性并保护其供应链。因此，从上面这句话来看，市场受到了影响，预计随着经济活动的恢復，市场将迅速获得牵引力。

全球血管造影套件市场报告提供大约 45 多个市场数据表、40 多个图表和 180 页内容。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 预计介入肿瘤学中精密 CT 系统的技术进步将推动市场增长。
    • 限制因素
      • 与安装血管造影套件相关的高成本预计会阻碍市场增长。
    • 市场机会
    • 影响分析

第五章行业分析

  • 供应链分析
  • 定价分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 单机
  • 双翼飞机

第 8 章按设备

  • X 射线发生器
  • C型臂
  • X 射线探测器
  • 手术台
  • 其他

第 9 章。按应用程序

  • 血管成形术
  • 支架治疗
  • 闭塞性搭桥手术
  • 血管内治疗
  • 椎板成形术
  • 骨髓造影剂
  • 动静脉畸形手术
  • 冠状动脉造影
  • 其他

第 10 章，最终用户

  • 医院
  • 诊断中心
  • 心血管导管实验室
  • 其他

第 11 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 12 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 13 章公司简介

  • 西门子医疗保健有限公司
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Carestream Health
  • Canon Medical Systems Corporation
  • Shimadzu Corp
  • 3D Systems
  • IMRIS

第 14 章全球血管造影套件市场 - DataM

简介目录
Product Code: DMMI5803

Market Overview

The Angio Suites Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5% during the forecast period (2022-2029).

Angio suites are well-resourced, multipurpose areas used to carry out interventional vascular procedures. These facilities carry out several medical treatments, including minimally invasive endovascular surgery, ischemic stroke treatment, myelograms, aortic dissection, ruptured aneurysms, diagnostic imaging techniques, and medical imaging practices. The Angio suites' adaptability is a real asset because it allows for the execution of numerous medical operations. Angio suites offer a one-stop solution to patients, reducing the real trauma of the surgery by eliminating the need for patients to transition between various operating rooms.

Market Dynamics

Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.

Interventional radiology greatly benefits from combined angiography-CT (angio-CT) systems, which combine standard angiographic imaging with cross-sectional imaging. Although flat-panel angiography systems' cone-beam CT (CBCT) technology has long been used as an adjunct cross-sectional imaging tool during interventional procedures, the inherent benefits of angio-CT systems' superior soft-tissue imaging and contrast resolution, as well as their ease of operation, have reignited interest in their application to interventional oncology procedures. Angio-CT systems have emerged as a competitive alternative to standalone flat-panel angiographic systems with CBCT due to gains in pricing and usability brought on by improved workflow. Additionally, cross-sectional imaging from the CT scanner and fluoroscopic imaging from the angiography system are combined to more precisely plan oncologic interventions, combine multiple therapies in one location, and track intraprocedural treatment responses, minimizing complications and enhancing therapeutic outcomes. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High costs associated with arranging angio suites, lacking skilled personnel who are proficient at using angio suites and increasing usage of reconditioned diagnostic imaging equipment, and significant radiation exposure risk are some of the factors the market is expected to hamper in the forecast period.

Industry Analysis

The angio suites market provides in-depth analysis of the market based on various industry factors such as porter's five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Heart disease and other chronic disease cases increased during the pandemic while the coronavirus was active. Because angio suites are the cutting-edge interventions used for precise and effective diagnosis that aid in visualizing the interior of human blood vessels, particularly the arteries, demand for them has skyrocketed. The abrupt and uncontrolled rise in COVID-19 cases led to a surge in patients with heart disease, raising the need for modern angio suites. The Centers for Disease Control and Prevention suggested postponing elective cardiac procedures, such as coronary angiography and percutaneous coronary intervention for stable coronary artery disease, to conserve resources, including personal protective equipment and hospital beds to care for COVID-19 patients. During the early stages of the COVID epidemic, it is predicted that STEMI activations in cardiac catheterization laboratories in the United States decreased by 38%, matching the 40% reduction seen in Spain.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Angioplasty segment is expected to hold the largest market share in angio suites market

The angioplasty segment is expected to dominate in 2021. The segment is beneficial because angioplasty is a procedure used to open coronary arteries that have become blocked due to coronary artery disease. Additionally, angioplasty has fewer scars, lessens post-operative side effects, a greater success rate, low invasion, and quick recovery. Additionally, as the burden of coronary heart disease rises, the demand for angioplasty increases since it can be used to enlarge blocked or restricted coronary arteries, keeping the patient safe. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global angio suites market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of cardiovascular diseases, rising investments in research & development, increasing high-quality medical facilities, including hospitals and laboratories, high level of awareness of healing difficulties and the availability of effective treatments and product launches and acquisitions by the key market players are some of the factors the market is expected to boost in the forecast period. For instance, In the United States, heart disease is the leading cause of death for both sexes and members of most racial and ethnic groups. Cardiovascular disease claims one life in the United States every 36 seconds. One in four deaths in the US is caused by heart disease, which affects about 659,000 people annually. Moreover, according to the American Heart Association, in 2019, at least 48 percent of adults in the United States suffer from cardiovascular disease.

Additionally, a subsidiary of renowned Massachusetts-based firm General Electric, GE Healthcare, announced the successful acquisition of Boston, Massachusetts-based imaging company "BK Medical" on December 21, 2021. The deal has been completed with a $1.45 billion payment from GE. Furthermore, the deal has helped GE Healthcare's ultrasound division grow. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the angio suites market are Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Carestream Health, Canon Medical Systems Corporation, Shimadzu Corp, 3D Systems, IMRIS.

3D Systems:

Overview:

A 3D printing service is provided by 3D Systems, a business with its main office in Rock Hill, South Carolina, which also designs, produces, and sells 3D printers, 3D printing supplies, and 3D scanners. The business produces master patterns for tooling, functional prototypes, production parts for direct digital manufacturing, and concept models for new product ideas. Input from computer-aided design and manufacturing software, 3D scanning, and 3D sculpting tools is used to produce real products utilizing proprietary techniques. Numerous industries, including aerospace, automotive, healthcare, dental, entertainment, and the creation of durable goods, employ the technologies and services provided by 3D Systems. The business provides a selection of 3D printers suitable for professional and industrial use, software, materials, and an online service for producing quick parts.

Product Portfolio:

Simulator-Angio-Mentor: ANGIO Mentor simulators provide multi-specialty hands-on practice of endovascular interventions in an extensive simulated clinical environment of a cath lab, interventional suite or a hybrid operating room. It provides a complete individual and team training solutions to learners of all levels.

The global angio suites market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. High costs associated with arranging angio suites is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Single plane*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Biplane

8. By Equipment

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 8.1.2. Market Attractiveness Index, By Equipment Segment
  • 8.2. X-Ray Generator*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. C-Arm
  • 8.4. X-Ray Detector
  • 8.5. Operating Table
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Angioplasty*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Therapeutic Stenting
  • 9.4. Obstruction Bypasses
  • 9.5. Intravascular Therapy
  • 9.6. Vertebroplasty
  • 9.7. Myelograms
  • 9.8. Arterial venous malformations surgery
  • 9.9. Coronary angiograms
  • 9.10. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Centers
  • 10.4. Cardiovascular catheterization laboratories
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Siemens Healthcare GmbH*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Koninklijke Philips N.V.
  • 13.3. GE Healthcare
  • 13.4. Carestream Health
  • 13.5. Canon Medical Systems Corporation
  • 13.6. Shimadzu Corp
  • 13.7. 3D Systems
  • 13.8. IMRIS

LIST NOT EXHAUSTIVE

14. Global Angio Suites Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us